LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.003
 58.15 27.76 220 5906 0.0372 0.3069
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 58.15 27.76 2989 5906 0.5060 0.8314
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 58.15 27.76 2064 5906 0.3494 0.7458
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 58.15 27.76 2413 5906 0.4085 0.7814
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 58.15 27.76 404 5906 0.0684 0.4138
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 58.15 27.76 3626 5906 0.6139 0.8777
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 59.85 27.76 234 6062 0.0386 0.3157
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 59.85 27.76 3118 6062 0.5143 0.8360
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 59.85 27.76 2131 6062 0.3515 0.7482
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 59.85 27.76 2435 6062 0.4016 0.7785
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 59.85 27.76 491 6062 0.0810 0.4473
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 59.85 27.76 3735 6062 0.6161 0.8791
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 61.56 27.76 253 6217 0.0407 0.3272
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 61.56 27.76 3230 6217 0.5195 0.8391
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 61.56 27.76 2131 6217 0.3428 0.7437
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 61.56 27.76 2599 6217 0.4180 0.7886
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 61.56 27.76 575 6217 0.0925 0.4743
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 61.56 27.76 3899 6217 0.6271 0.8840
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 63.26 27.76 277 6465 0.0428 0.3398
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 63.26 27.76 3361 6465 0.5198 0.8403
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 63.26 27.76 2072 6465 0.3205 0.7305
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 63.26 27.76 2533 6465 0.3918 0.7753
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 63.26 27.76 600 6465 0.0928 0.4782
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 63.26 27.76 4028 6465 0.6230 0.8832
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 64.97 27.76 289 6656 0.0434 0.3449
MN20160318_Q01
E20